Digital health is bringing new solutions that are transforming the lives of thousands of people with cardiac disease.

In October 2021, AstraZeneca and Slush joined forces with a few start-ups and entrepreneurs for a collaborative event providing a…

Countless new health tech innovations may have popped up over the past two years, but has it been enough to overcome hesitancy toward telehealth.

Today the Baker Heart and Diabetes Institute announced a world leading investigation into the long-term heart damage caused by COVID-19.

We are delighted to have the ImpaQT Group’s support and investment to help us to fulfil our mission of improving access to care for patients recovering from cardiac events and/or living with heart disease.

Digital health will take transformative steps by supporting new clinical trials to address secondary prevention of Australia’s deadliest disease following an agreement between Australian digital health company Cardihab and medical research organisation, the Baker Heart and Diabetes Institute.

Read how Cardihab and Baker Heart and Diabetes Institute, a medical research organisation in Melbourne, have signed a five-year agreement to jointly conduct clinical trials and cohort studies.

The webinar hosted by Australian Healthcare and Hospitals Association (AHHA) is now available to watch.

Cardihab’s recent raise campaign via the VentureCrowd crowd funding platform caught the interest of journalist Jonathan Porter from the Australian Financial Review.

The Australian first partnership between Uniseed and VentureCrowd provides an important pathway for wholesale investors to support the growth and expansion of home grown digital health companies like Cardihab to achieve our potential.

The Australian Centre for Value-Based Health Care is pleased to bring you the next webinar in our webinar series on ‘How digital solutions to cardiac rehabilitation are transforming patient outcomes’.

Tassie Talks LAFM Host Michael O’Loughlin interviews Helen Souris CEO Cardihab.